Pharmaceutical companies face complex challenges when expanding their operations, especially in regions like Pennsylvania and New York. These challenges include managing large-scale engineering projects, navigating regulatory requirements, and controlling costs. Two multi-billion-dollar pharmaceutical companies recently undertook significant expansion projects in these states. Their approach to project engineering staffing offers valuable lessons on balancing financial prudence, regulatory compliance, and talent management.
This post explores how these companies structured their engineering staffing to support their expansions, avoid exposure to the WARN Act, and use multi-year consulting budgets to gradually augment their teams. Understanding these strategies can help other organizations planning similar projects in regulated industries.
Understanding the Challenges of Pharma Expansion Projects
Pharmaceutical expansions require careful planning across multiple disciplines, including architecture, engineering, and project management. The stakes are high because:
Regulatory compliance is strict, especially regarding labor laws like the WARN Act, which mandates advance notice for large layoffs.
Talent needs fluctuate during different project phases, from design to construction to commissioning.
Financial management must balance upfront costs with long-term operational efficiency.
In Pennsylvania and New York, these challenges are compounded by local labor laws and competitive markets for skilled engineers and architects.
Avoiding WARN Act Exposure Through Staffing Strategies
The WARN Act requires employers to provide 60 days’ notice before mass layoffs or plant closings. For large pharma companies, this can pose a significant risk if staffing needs change suddenly during a project.
To avoid this, the companies adopted a gradual staffing approach using consulting contracts rather than direct hires. This approach allowed them to:
Scale staff up or down based on project phases without triggering WARN Act requirements.
Maintain flexibility to adjust resources as project demands evolved.
Reduce financial risk by spreading costs over multiple years.
For example, during the initial design phase, a smaller team of architects and engineers was contracted. As the project moved into construction, additional consultants with specialized skills were brought in gradually.
Using Multi-Year Consulting Budgets to Manage Costs and Talent
Large pharma expansions often span several years, making budgeting a challenge. The companies addressed this by setting up multi-year consulting budgets that provided:
Predictable financial planning for staffing costs over the project lifecycle.
Flexibility to allocate funds to different specialties as needed.
Opportunities to build long-term relationships with consulting firms, improving knowledge retention.
This budgeting method also helped avoid the pitfalls of hiring full-time staff too early or too late, which can lead to idle resources or rushed recruitment.
Staffing Architecture and Engineering Teams for Complex Projects
The expansion projects required a mix of architectural design and engineering expertise, including:
Civil and structural engineers to design new facilities.
Mechanical and electrical engineers for HVAC, power, and automation systems.
Architects specializing in pharmaceutical cleanroom design.
Project engineers to coordinate schedules, budgets, and compliance.
The companies used a phased staffing model:
Concept and feasibility phase: Small core team to develop initial designs and cost estimates.
Detailed design phase: Expanded team with specialists to finalize plans.
Construction phase: Larger team including project engineers and quality assurance experts.
Commissioning and validation phase: Experts to ensure facilities meet regulatory standards.
This model allowed the companies to bring in the right talent at the right time, avoiding overstaffing and reducing costs.
Practical Examples of Staffing Adjustments
One company faced a sudden change in project scope due to updated FDA requirements. Instead of hiring new full-time staff, they:
Increased consulting hours for compliance engineers.
Reassigned some architectural consultants to focus on new cleanroom specifications.
Delayed hiring for construction oversight until designs were finalized.
This approach minimized disruption and avoided layoffs that could have triggered WARN Act notices.
Another example involved cross-state coordination between Pennsylvania and New York sites. The companies used shared consulting teams to:
Ensure consistent design standards.
Share best practices.
Optimize resource allocation across both projects.
This collaboration reduced duplication and improved project timelines.
Benefits of Strategic Staffing for Pharma Expansions
The staffing strategies used by these companies delivered several benefits:
Regulatory risk reduction by avoiding WARN Act exposure.
Cost control through phased hiring and multi-year budgets.
Talent flexibility to meet changing project demands.
Improved project outcomes by aligning staffing with project phases.
Knowledge continuity through long-term consulting relationships.
These benefits contributed to smoother project execution and better financial management.
Key Takeaways for Pharma and Engineering Leaders
Organizations planning large pharma expansions can apply these lessons:
Use consulting contracts to maintain staffing flexibility and avoid labor law risks.
Develop multi-year budgets to manage staffing costs over the project lifecycle.
Align staffing levels with project phases to optimize resource use.
Foster collaboration across sites with shared consulting teams.
Monitor regulatory changes closely to adjust staffing plans proactively.
By adopting these strategies, companies can build strong project engineering teams that support successful expansions without unnecessary financial or legal risks.
